JonathanEKaplanMD

PubMed

• Change in plasma CrAg titer is not associated with survival among HIV-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia.
  Pullen, M. F.,Kakooza, F.,Nalintya, E.,Kiragga, A. N.,Morawski, B. M.,Rajasingham, R.,Mubiru, A.,Manabe, Y. C.,Kaplan, J. E.,Meya, D. B.,Boulware, D. R.> ;Clin. Infect. Dis.. 2019 May 24
• Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cel...
  Meya, D. B.,Kiragga, A. N.,Nalintya, E.,Morawski, B. M.,Rajasingham, R.,Park, B. J.,Mubiru, A.,Kaplan, J. E.,Manabe, Y. C.,Boulware, D. R.> ;J. Acquir. Immune Defic. Syndr.. 2018 Nov 07
• Epidemiology of HIV-Associated Lung Disease in the United States.
  Fitzpatrick, M.,Brooks, J. T.,Kaplan, J. E.> ;Semin Respir Crit Care Med. 1900 Jan 01
• 92 citations
  Global Epidemiology of HIV
  Jade Fettig, Mahesh Swaminathan, Christopher S. Murrill, Jonathan E. Kaplan> ;Infectious Disease Clinics of North America. 2014 Sep 1
• Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents--Updated Guidelines from CDC, NIH, and HIVMA of the IDSA.
  Masur, H.,Brooks, J. T.,Benson, C. A.,Holmes, K.,Pau, A.,Kaplan, J. E.> ;Clin. Infect. Dis.. 2014 Mar 04
• Preventing Malaria in HIV-Infected Pregnant Women.
  Bulterys, P. L.,Kaplan, J. E.,Gutman, J.> ;Clin. Infect. Dis.. 2013 Dec 18
• What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
  Brooks, J.T., Kaplan, J.E., Masur, H.> ;Top HIV Med. 2009-07-01
• New guidelines for the management of HIV-related opportunistic infections.
  Masur, H., Kaplan, J.E.> ;JAMA. 2009-06-10
• HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines.
  Brooks, J.T., Kaplan, J.E., Holmes, K.K., Benson, C., Pau, A., Masur, H.> ;Clin Infect Dis. 2009-03-01
• Cost-effectiveness of HIV treatment in resource-poor settings--the case of C&Atilde;&acute;te d'Ivoire.
  Goldie, S.J., Yazdanpanah, Y., Losina, E., Weinstein, M.C., Anglaret, X., Walensky, R.P., Hsu, H.E., Kimmel, A., Holmes, C., Kaplan, J.E., Freedberg, K.A.> ;N Engl J Med. 2006 Sep 14
• Current epidemiology of Pneumocystis pneumonia.
  Morris, A., Lundgren, J.D., Masur, H., Walzer, P.D., Hanson, D.L., Frederick, T., Huang, L., Beard, C.B., Kaplan, J.E.> ;Emerg Infect Dis. 2004 Oct
• The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.
  Weinstock, H.S., Zaidi, I., Heneine, W., Bennett, D., Garcia-Lerma, J.G., Douglas, J.M., LaLota, M., Dickinson, G., Schwarcz, S., Torian, L., Wendell, D., Paul, S., Go...> ;J Infect Dis. 2004 Jun 15
• 3 citations
  Insulin resistance complicating pregnancy in a human immunodeficiency virus–infected patient treated with protease inhibitors and corticosteroids
  Sarit Aschkenazi, Burton Rochelson, James Bernasko, Jonathan Kaplan> ;Obstetrics and Gynecology. 2003 Nov 1
• A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.
  García-Lerma, J. G., MacInnes, H., Bennett, D., Reid, P., Nidtha, S., Weinstock, H., Kaplan, J. E., Heneine, W.> ;J Virol. 2003 May
• Discontinuing prophylaxis against recurrent opportunistic infections in HIV-infected persons: a victory in the era of HAART.
  Kaplan, J.E., Masur, H., Holmes, K.K.> ;Ann Intern Med. 2002 Aug 20
• Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
  Goldie, S.J., Kaplan, J.E., Losina, E., Weinstein, M.C., Paltiel, A.D., Seage, G.R., Craven, D.E., Kimmel, A.D., Zhang, H., Cohen, C.J., Freedberg, K.A.> ;Arch Intern Med. 2002 Apr 22
• Low prevalence of human T-lymphotropic virus type I among patients with tuberculosis in Senegal.
  Kaplan, J. E., Camara, T., Hanne, A., Green, D., Khabbaz, R., LeGuenno, B.> ;J Acquir Immune Defic Syndr. 1994 Apr
• Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A.
  Vlahov, D., Khabbaz, R. F., Cohn, S., Galai, N., Taylor, E., Kaplan, J. E.> ;J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1
• 14-year follow-up of HIV-infected homosexual men with lymphadenopathy syndrome.
  Kaplan, J. E., Spira, T. J., Fishbein, D. B., Lyn, H. S.> ;J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1
• A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?
  Holmes, G. P., Kaplan, J. E., Stewart, J. A., Hunt, B., Pinsky, P. F., Schonberger, L. B.> ;JAMA. 1987 May 1
• Unexplained lymphadenopathy in homosexual men. A longitudinal study.
  Fishbein, D. B., Kaplan, J. E., Spira, T. J., Miller, B., Schonberger, L. B., Pinsky, P. F., Getchell, J. P., Kalyanaraman, V. S., Braude, J. S.> ;JAMA. 1985 Aug 16
• HTLV-III viremia in homosexual men with generalized lymphadenopathy.
  Kaplan, J. E., Spira, T. J., Feorino, P. M., Warfield, D. T., Fishbein, D. B.> ;N Engl J Med. 1985 Jun 13
• The syndrome of unexplained generalized lymphadenopathy in young men in New York City. Is it related to the acquired immune deficiency syndrome?
  Miller, B., Stansfield, S. K., Zack, M. M., Curran, J. W., Kaplan, J. E., Schonberger, L. B., Falk, H., Spira, T. J., Mildvan, D.> ;JAMA. 1984 Jan 13
• Suspected Rocky Mountain spotted fever in the winter--epidemic typhus?
  Kaplan, J. E., McDade, J. E., Newhouse, V. F.> ;N Engl J Med. 1981 Dec 31
• Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficie...
  McDougal, J. S., Kennedy, M. S., Nicholson, J. K., Spira, T. J., Jaffe, H. W., Kaplan, J. E., Fishbein, D. B., O'Malley, P., Aloisio, C. H., Black, C. M.> ;J Clin Invest. 1987 Aug
• Join now to see all